From the Department of Emergency Medicine (J.F., H.K.K., R.C.W.), Center for Healthcare Value (J.F.), Philip R. Lee Institute for Health Policy Studies (H.K.K.), and Department of Radiology and Biomedical Imaging (J.M.), University of California, San Francisco, 505 Parnassus Ave, L126, San Francisco, CA 94143-0209; Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, Calif (K.L.K.); and RAND Corporation, Santa Monica, Calif (K.L.K.).
Radiology. 2019 Apr;291(1):188-193. doi: 10.1148/radiol.2019181650. Epub 2019 Jan 29.
Background Clinical decision support is increasingly used to enhance clinicians' exposure to established evidence and patient information during an episode of patient care. Pending legislation specifies clinical decision support before performing advanced imaging at emergency department (ED) visits. Purpose To estimate the volume of advanced imaging tests (CT and MRI) that would require use of clinical decision support to achieve Protecting Access to Medicare Act (PAMA) compliance in the ED. Materials and Methods A retrospective, cross-sectional analysis of ED visits was conducted by using data from the 2012-2015 National Hospital Ambulatory Care Survey. PAMA-related visits were identified by selecting the patient reasons for visit (RFVs) related to the eight clinical conditions. Results Among the adult ED visits, 26.7% (20 506 of 77 299, representing 113 000 000 visits across 4 years, or 28 000 000 visits annually) patients presented with a RFV consistent with a PAMA priority clinical area (PCA). Among visits in which a patient described an RFV code consistent with a PAMA PCA, up to 22.9% (4681 of 20 506; 95% confidence interval: 21.8%, 24.1%) patients underwent advanced imaging, translating to approximately 6 000 000 visits annually. Conclusion Protecting Access to Medicare Act legislation targets eight priority clinical areas, estimated to be prevalent among one in four adult emergency department visits. CT and/or MRI studies are performed during up to 23% of these visits. Depending on the particular clinical decision support systems selected within a health system, and how they are implemented, the potential volume of studies in which clinicians must interact with clinical decision support system may either exceed or fall short of these estimates. © RSNA, 2019 Online supplemental material is available for this article. See also the editorial by Forman in this issue.
背景 临床决策支持系统越来越多地用于在患者护理期间增强临床医生对既定证据和患者信息的了解。待决立法规定在急诊科就诊时进行高级影像学检查之前使用临床决策支持系统。
目的 估计需要使用临床决策支持系统来实现《保护医疗保险获取法》(PAMA)在急诊科合规的高级影像学检查(CT 和 MRI)的数量。
材料和方法 使用 2012-2015 年全国医院门诊调查的数据,对急诊科就诊进行回顾性横断面分析。通过选择与 8 种临床情况相关的就诊原因(RFV),确定与 PAMA 相关的就诊。
结果 在成年急诊科就诊中,26.7%(77299 例中的 20506 例,代表 4 年期间的 1.13 亿次就诊,或每年 2800 万次就诊)患者的就诊 RFV 与 PAMA 优先临床领域(PCA)一致。在就诊 RFV 代码与 PAMA PCA 一致的就诊中,高达 22.9%(20506 例中的 4681 例;95%置信区间:21.8%,24.1%)患者接受了高级影像学检查,每年约 600 万次就诊。
结论 PAMA 立法针对 8 个优先临床领域,估计在四分之一的成年急诊科就诊中普遍存在。在这些就诊中,有 23%的患者进行了 CT 和/或 MRI 检查。根据特定的卫生系统中选择的临床决策支持系统及其实施方式,临床医生必须与临床决策支持系统交互的研究数量可能超过或低于这些估计。